A Clinical Trial of an Experimental Treatment for Mitochondrial Disease Has Produced Promising Results
Two organisations, NeuroVive Pharmaceutical AB from Sweden and Yungjin Pharm Corporation based in South Korea, have announced encouraging initial results from a Phase I clinical trial of the experimental medicine…